PathGroup’s Pranil K. Chandra, DO, FCAP, FASCP to Speak at 2017 Molecular Medicine Tri-Conference

Brentwood, TN – (Thursday, February 16, 2017) – PathGroup, one of the largest private providers of pathology and laboratory services in the Unites States, is pleased to announce that Pranil K. Chandra, DO, FCAP, FASCP,  Vice President and Chief Medical Officer and Medical Director,  Genomic and Clinical Pathology Services at PathGroup, will speak at the 2017 Molecular Medicine Tri-Conference  in San Francisco, CA on Monday, February 20, 2017.

Dr. Chandra’s session “Garnering Payer Support for Genomic Profiling by Demonstrating Clinical Utility” will review PathGroup’s experience with certain payers in garnering appropriate reimbursement for genomic profiling. In addition, he will review how to demonstrate clinical utility through illustrative examples highlighting diagnostic, prognostic, and/or therapeutic utility across hematologic and solid tumor malignancies.

For more information on the 2017 Molecular Medicine Tri-Conference please visit,